OAM
MIST icon

Oxford Asset Management’s Milestone Pharmaceuticals MIST Stock Holding History

Oxford Asset Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-19,715
Closed -$316K – 844
2019
Q4 		$316K Sell
19,715
-6,382
-24% -$113K 0.01% 1416
2019
Q3 		$451K Sell
26,097
-4,625
-15% -$91K 0.01% 1300
2019
Q2 		$834K Buy
+30,722
New +$634K 0.02% 1057

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oxford Asset Management's MIST Position: Q1 2020 in Review

Oxford Asset Management sold out of Milestone Pharmaceuticals (MIST) in Q1 2020, closing a stake of 19,715 shares — an estimated $316K sold.

Oxford Asset Management first reported a position in MIST in Q2 2019 and held it in 3 quarters. The position peaked at $834K in Q2 2019. 19 funds tracked by Wall St. Rank hold MIST as of Q1 2020.

  • Oxford Asset Management reported no remaining Milestone Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 19,715 Milestone Pharmaceuticals shares in Q1 2020, an estimated $316K.
  • Oxford Asset Management first reported a position in Milestone Pharmaceuticals in Q2 2019 and held it in 3 quarters.
  • Oxford Asset Management's Milestone Pharmaceuticals position peaked at $834K in Q2 2019.
  • 19 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.